Averin Capital Acquisition Corp.(NASDAQ) ACAA

Averin Capital Acquisition Corp. is a blank check company. It raises money to buy a private business. This helps that company go public.

The Business Plan

• Target Search: Identifying potential merger partners at the intersection of technology and health.
• Trust Management: Overseeing funds kept in a secure account for a future business combination.
• Public Listing: Enabling a private company to trade on the Nasdaq through a merger or asset purchase.

Milestones on the Merger Path

• Incorporated on Oct. 17, 2025, to pursue a strategic business combination.
• Closed an initial public offering on Feb. 20, 2026, raising $250 million.
• Raised $33.9 million in extra proceeds on March 5, 2026, via an over-allotment option.
• Completed a $2 million private placement sale to its sponsor in February 2026.

A Specific Industry Focus

Averin focuses on finding a partner where technology and healthcare meet. The company has until Feb. 20, 2028, to complete a deal or return the held money to its shareholders.

Checking the Books

• Net income reached $2.4 million for the three months ended June 30, 2026.
• Trust account investments grew to $287.4 million by June 30, 2026.
• Interest income totaled $3.5 million for the six months ended June 30, 2026.
• Cash held outside the trust account was $339,276 as of June 30, 2026.

The Big Picture

Averin has shifted from a new shell entity to a funded acquisition vehicle. Its success hinges on finding a suitable health-tech merger partner within its two-year window.